申请人:Thombare Pravin S.
公开号:US20090171091A1
公开(公告)日:2009-07-02
Disclosed herein in the embodiments of the present invention are the compounds suitable as modulators of HDL having general formula (1), novel intermediates involved in their synthesis, their pharmaceutically acceptable salts and pharmaceutical compositions containing them. The present invention also relates to a process of preparing compounds of general formula (1), their tautomeric forms, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, and novel intermediates involved in their synthesis.
本发明实施例中披露的化合物具有一般式(1),适用于高密度脂蛋白(HDL)调节剂,以及其合成中所涉及的新型中间体、其药学上可接受的盐和含有它们的制药组合物。本发明还涉及制备一般式(1)化合物的方法、它们的互变异构体形式、其药学上可接受的盐、含有它们的制药组合物以及其合成中所涉及的新型中间体。